Elbasvir + Grazoprevir

Elbasvir/grazoprevir (trade name Zepatier /zptr/ ZEP--teer) is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and treatment-experienced patients.[1] Both elbasvir and grazoprevir were developed by Merck & Co. The US Food and Drug Administration (F... [wikipedia]